ChiCTR2600127219 版本V1.0 版本创建时间2026/06/26 16:04:21 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600127219 

最近更新日期:

Date of Last Refreshed on:

2026-06-26 16:04:13 

注册时间:

Date of Registration:

2026-06-26 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

儿童支气管舒张试验全国多中心研究及标准的建立

Public title:

National Multicenter Study of Bronchodilator Test in Children and Establishment of Its Standard

注册题目简写:

English Acronym:

研究课题的正式科学名称:

儿童支气管舒张试验全国多中心研究及标准的建立

Scientific title:

National Multicenter Study of Bronchodilator Test in Children and Establishment of Its Standard

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

尹若彤 

研究负责人:

张皓 

Applicant:

Yin Ruotong 

Study leader:

Zhang Hao 

申请注册联系人电话:

Applicant telephone:

+86 21 3862 6161

研究负责人电话:

Study leader's
telephone:

+86 21 3862 6161

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

17356519859@163.com

研究负责人电子邮件:

Study leader's E-mail:

zhang123hao2004@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区红曲路520号

研究负责人通讯地址:

上海市浦东新区红曲路520号

Applicant address:

520 Hongqu Road, Pudong New Area, Shanghai, China

Study leader's address:

520 Hongqu Road, Pudong New Area, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海交通大学医学院附属上海儿童医学中心

Applicant's institution:

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

研究负责人所在单位:

上海交通大学医学院附属上海儿童医学中心

Affiliation of the Leader:

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

SCMCIRB-K2025181-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海交通大学医学院附属上海儿童医学中心伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2025-09-30 00:00:00

伦理委员会联系人:

杨臻禹

Contact Name of the ethic committee:

Yang Zhenyu

伦理委员会联系地址:

上海市浦东新区红曲路520号

Contact Address of the ethic committee:

520 Hongqu Road, Pudong New Area, Shanghai, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 3862 6161

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海交通大学医学院附属上海儿童医学中心

Primary sponsor:

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

研究实施负责(组长)单位地址:

上海市浦东新区红曲路520号

Primary sponsor's address:

520 Hongqu Road, Pudong New Area, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海交通大学医学院附属上海儿童医学中心

具体地址:

上海市浦东新区红曲路520号

Institution
hospital:

Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine

Address:

520 Hongqu Road, Pudong New Area, Shanghai

经费或物资来源:

自筹

Source(s) of funding:

Self-funding

研究疾病:

支气管哮喘  

Target disease:

Bronchial asthma

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

本研究希望通过全国多中心的研究,了解哮喘孩子在支气管舒张剂后临床和肺功能的改善,并建立中国儿童支气管舒张试验的阳性诊断标准,适时修改指南,指导临床诊断和治疗。造福呼吸道疾病尤其是哮喘的患儿和家长。  

Objectives of Study:

This study aims to investigate the clinical and lung function improvement of asthmatic children after bronchodilators through a nationwide multicenter study, establish positive diagnostic criteria for bronchodilators in Chinese children, revise guidelines in a timely manner, and guide clinical diagnosis and treatment. Benefit children and parents with respiratory diseases, especially asthma.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

病例组: 1.5-17岁、身高、体重正常范围的哮喘患儿; 2.在中国出生, 孩子父母都是中国人; 3.哮喘急性发作期; 4.检测前6小时未用过雾化或口服短效支气管扩张剂,12小时未用中效支气管扩张剂,24小时内未用过抗组胺药、长效支气管扩张剂、白三烯受体拮抗剂; 5.智力发育正常,能很好配合; 对照组: 1.5-17岁、身高、体重正常范围的哮喘患儿; 2.在中国出生, 孩子父母都是中国人; 3.无哮喘、鼻炎等过敏性疾病; 4.一月内无呼吸道感染病史或其他疾病影响呼吸系统

Inclusion criteria

Case group: 1. Asthmatic children aged 5 - 17 years with normal height and weight; 2. Born in China, with both parents being Chinese; 3. During the acute attack of asthma; 4. No use of nebulization or short-acting bronchodilators within 6 hours before the test, no use of medium-acting bronchodilators within 12 hours, and no use of antihistamines, long-acting bronchodilators, or leukotriene receptor antagonists within 24 hours; 5. Normal intellectual development, able to cooperate well; Control group: 1. Asthmatic children aged 5 - 17 years with normal height and weight; 2. Born in China, with both parents being Chinese; 3. Without allergic diseases such as asthma or rhinitis; 4. No history of respiratory infections or other diseases affecting the respiratory system within one month.

排除标准:

1.非哮喘原因导致的喘息; 2.有先天性心、肺、神经系统疾病; 3.气道畸形; 4.中重度肥胖或营养不良者; 5.过矮或过高的患儿; 6.重症发作须送ICU 的; 7.已使用过支气管扩张药。

Exclusion criteria:

1. Wheezing not caused by asthma; 2. Having congenital heart, lung or nervous system diseases; 3. Airway malformations; 4. Moderately to severely obese or malnourished individuals; 5. Children who are too short or too tall; 6. Those with severe attacks requiring transfer to the ICU; 7. Those who have already used bronchodilators.

研究实施时间:

Study execute time:

From 2026-06-26 00:00:00 To 2028-06-25 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-26 00:00:00 To 2028-06-25 00:00:00

干预措施:

Interventions:

组别:

病例组

样本量:

2800

Group:

Case group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

对照组

样本量:

2800

Group:

Control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

湖北省 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

武汉妇幼保健院 

单位级别:

三甲 

Institution
hospital:

Wuhan Maternal and Child Health Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

吉林省 

市(区县):

 

Country:

China

Province:

Jilin

City:

单位(医院):

吉林大学第一医院 

单位级别:

三甲 

Institution
hospital:

The First Hospital of Jilin University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

贵州省 

市(区县):

 

Country:

China

Province:

Guizhou

City:

单位(医院):

贵阳市儿童医院 

单位级别:

三甲 

Institution
hospital:

Guiyang Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南省 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

湖南省人民医院 

单位级别:

三甲 

Institution
hospital:

Hunan Provincial People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山西省 

市(区县):

 

Country:

China

Province:

Shanxin

City:

单位(医院):

山西省儿童医院 

单位级别:

三甲 

Institution
hospital:

Shanxi Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山市博爱医院 

单位级别:

三甲 

Institution
hospital:

Zhongshan Boai Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

佛山市妇幼保健院 

单位级别:

三甲 

Institution
hospital:

Foshan Maternal and Child Health Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

辽宁省 

市(区县):

 

Country:

China

Province:

Liaoning

City:

单位(医院):

中国医科大学附属盛京医院 

单位级别:

三甲 

Institution
hospital:

Shenyang General Hospital of China Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

重庆市 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属儿童医院 

单位级别:

三甲 

Institution
hospital:

Children's Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河南省 

市(区县):

 

Country:

China

Province:

Henan

City:

单位(医院):

河南省妇幼保健院郑州大学第三附属医院 

单位级别:

三甲 

Institution
hospital:

Henan Provincial Maternal and Child Health Hospital; the Third Affiliated Hospital of Zhengzhou University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山西省 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

山西白求恩医院 

单位级别:

三甲 

Institution
hospital:

Shanxi Baiqiuen Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

广州市妇儿中心 

单位级别:

三甲 

Institution
hospital:

Guangzhou Women and Children's Center

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

辽宁省 

市(区县):

 

Country:

China

Province:

Liaoning

City:

单位(医院):

大连市儿童医院 

单位级别:

三甲 

Institution
hospital:

Dalian Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

天津市 

市(区县):

 

Country:

China

Province:

Tianjin

City:

单位(医院):

天津市儿童医院 

单位级别:

三甲 

Institution
hospital:

Tianjin Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

福建省 

市(区县):

 

Country:

China

Province:

Fujian

City:

单位(医院):

福建省儿童医院 

单位级别:

三甲 

Institution
hospital:

Fujian Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

 

Country:

China

Province:

Inner Mongolia Autonomous Region

City:

单位(医院):

内蒙古自治区人民医院 

单位级别:

三甲 

Institution
hospital:

The Children's Hospital of Inner Mongolia Autonomous Region People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

陕西省 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

西安市儿童医院 

单位级别:

三甲 

Institution
hospital:

Xi'an Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

云南省 

市(区县):

 

Country:

China

Province:

Yunnan

City:

单位(医院):

昆明市儿童医院 

单位级别:

三甲 

Institution
hospital:

Kunming Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

新疆维吾尔自治区 

市(区县):

 

Country:

China

Province:

Xinjiang Uygur Autonomous Region

City:

单位(医院):

乌鲁木齐儿童医院 

单位级别:

三甲 

Institution
hospital:

Urumqi Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖北省 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

武汉同济医院 

单位级别:

三甲 

Institution
hospital:

Tongji Hospital of Wuhan University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江省 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江省儿童医院 

单位级别:

三甲 

Institution
hospital:

Zhejiang Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

湖南省 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

湖南妇女儿童医院 

单位级别:

三甲 

Institution
hospital:

Hunan Women and Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

上海市 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

复旦儿科医院 

单位级别:

三甲 

Institution
hospital:

Fudan Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

河南省 

市(区县):

 

Country:

China

Province:

Henan

City:

单位(医院):

洛阳市妇幼保健院 

单位级别:

三甲 

Institution
hospital:

Luoyang Maternal and Child Health Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

 

Country:

China

Province:

Inner Mongolia Autonomous Region

City:

单位(医院):

内蒙古自治区妇幼保健院 

单位级别:

三甲 

Institution
hospital:

Inner Mongolia Autonomous Region Maternal and Child Health Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

济南市儿童医院 

单位级别:

三甲 

Institution
hospital:

Jinan Children's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

山东省 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

山东省立医院 

单位级别:

三甲 

Institution
hospital:

Shandong Provincial Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

呼吸总阻抗

指标类型:

主要指标

Outcome:

Total respiratory impedance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

阻抗或阻力

指标类型:

主要指标

Outcome:

Impedance or resistance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

电抗

指标类型:

主要指标

Outcome:

Reactance

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

共振频率

指标类型:

主要指标

Outcome:

Resonance frequency

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

电抗面积

指标类型:

主要指标

Outcome:

Reactance area

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

第一秒用力呼气容积

指标类型:

主要指标

Outcome:

The volume of exhaled air in the first second

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

用力肺活量

指标类型:

主要指标

Outcome:

Maximum lung capacity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

最大呼气峰值流量

指标类型:

主要指标

Outcome:

Maximum expiratory peak flow

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

用力呼出50%肺活量时的瞬间呼气流量

指标类型:

主要指标

Outcome:

The instantaneous exhalation flow during the forced exhalation of 50% of the lung capacity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

用力呼出75%肺活量时的瞬间呼气流量

指标类型:

主要指标

Outcome:

The instantaneous expiratory flow during the forced exhalation of 75% of the total lung capacity

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

年龄

指标类型:

次要指标

Outcome:

Age

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

性别

指标类型:

次要指标

Outcome:

Gender

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疾病状态(哮喘急性发作,健康儿童)

指标类型:

次要指标

Outcome:

Disease status (acute asthma exacerbation,, healthy children)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 5 years
最大 Max age 17 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF;EDC

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF;EDC

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2026-06-26 16:04:13